Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

La veille scientifique est un service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS

T. APARICIO
B. DENIS
A. LOPEZ
S. MANFREDI
Y. TOUCHEFEU

E. CHABRUN
A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
B. HANSLIK
JL. PAYEN
PE. RAUTOU
D. VALLA

H. DAMON
F. CORDET
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
P. DELASALLE
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
New England Journal of Medicine (NEJM) Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component sep. 15 4 ♥ Foie
Journal of Hepatology Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension sep. 15 5 ♥ Foie
The Lancet Oncology Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial sep. 15 4 ♥ Cancer colorectal (CCR)
The Lancet Oncology Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial sep. 15 4 ♥ Carcinome hépatocellulaire (CHC)
The Lancet Oncology Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial sep. 15 3 ♥ Cancers autres (hors CCR et CHC), Cancer colorectal (CCR), Carcinome hépatocellulaire (CHC)
The Lancet Oncology Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial sep. 15 4 ♥ Cancers autres (hors CCR et CHC), Œsophage/Estomac
Hepatology Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort) sep. 15 4 ♥ Foie
Hepatology Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis sep. 15 3 ♥ Foie
Hepatology Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects sep. 15 2 ♥ Foie
Gastroenterology Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus aoû. 15 4 ♥ Endoscopie/Imagerie, Cancers autres (hors CCR et CHC)
Gastroenterology Quality Indicators for the Management of Barrett's Esophagus, Dysplasia and Esophageal Adenocarcinoma: International Consensus Recommendations from AGA Symposium aoû. 15 1 ♥ Endoscopie/Imagerie, Cancers autres (hors CCR et CHC), Œsophage/Estomac
Gastroenterology Incidence and Mortality of Colorectal Cancer in Individuals with a Family History of Colorectal Cancer aoû. 15 2 ♥ Endoscopie/Imagerie, Cancer colorectal (CCR), Génétique
Gastroenterology Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness aoû. 15 1 ♥ Endoscopie/Imagerie, Cancer colorectal (CCR)
Gastroenterology Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program aoû. 15 1 ♥ Endoscopie/Imagerie, Cancer colorectal (CCR)
Gut Appropriateness of endoscopic surveillance recommendations in organised colorectal cancer screening programmes based on the faecal immunochemical test aoû. 15 1 ♥ Endoscopie/Imagerie, Cancer colorectal (CCR)
Gastroenterology Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis aoû. 15 2 ♥ MICI
Gut Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry aoû. 15 5 ♥ Endoscopie/Imagerie, Œsophage/Estomac, Cancers autres (hors CCR et CHC)
Gut Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service aoû. 15 5 ♥ Endoscopie/Imagerie, Cancer colorectal (CCR)
Endoscopy Clinical outcomes in patients with a diagnosis of "indefinite for dysplasia" in Barrett's esophagus: a multicenter cohort study aoû. 15 2 ♥ Endoscopie/Imagerie, Œsophage/Estomac
Endoscopy Endoscopic mucosal resection of laterally spreading lesions involving the ileocecal valve: technique, risk factors for failure, and outcomes aoû. 15 3 ♥ Endoscopie/Imagerie, Pratiques professionnelles
Endoscopy Comparison of hemostatic forceps with soft coagulation versus argon plasma coagulation for bleeding peptic ulcer - a randomized trial aoû. 15 3 ♥ Endoscopie/Imagerie, Pratiques professionnelles
Gastrointestinal Endoscopy EUS-guided liver biopsy provides diagnostic samples at least comparable with percutaneous or transjugular routes aoû. 15 4 ♥ Endoscopie/Imagerie, Foie
Gastrointestinal Endoscopy Metachronous colorectal cancers result from missed lesions and non-compliance with surveillance aoû. 15 2 ♥ Endoscopie/Imagerie, Cancer colorectal (CCR)
Gut Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C aoû. 15 1 ♥ Foie, Hépatites virales
Gut Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians aoû. 15 5 ♥ Foie, Carcinome hépatocellulaire (CHC), Hépatites virales

Pages